文献
J-GLOBAL ID:202102274060123613
整理番号:21A0181413
Ticagrelorより広い治療窓を有する経口抗血小板薬としてのP2Y1とP2Y12の二重標的アンタゴニストへのキサンチンオキシダーゼ阻害剤のスイッチング【JST・京大機械翻訳】
Switching a Xanthine Oxidase Inhibitor to a Dual-Target Antagonist of P2Y1 and P2Y12 as an Oral Antiplatelet Agent with a Wider Therapeutic Window in Rats than Ticagrelor
著者 (16件):
Lei Yu
(Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, China)
,
Zhang Bing
(Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, China)
,
Liu Dan
(Shenyang Hinewy Pharmaceutical Technology Co., Ltd., China)
,
Zhao Jian
(Department of Pharmacology, Shenyang Pharmaceutical University, China)
,
Dai Xiwen
(Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, China)
,
Gao Jun
(Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, China)
,
Mao Qing
(Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, China)
,
Feng Yao
(Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, China)
,
Zhao Jiaxing
(Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, China)
,
Lin Fengwei
(Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, China)
,
Duan Yulin
(Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, China)
,
Zhang Yan
(Department of Pharmacology, Shenyang Pharmaceutical University, China)
,
Bao Ziyang
(Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, China)
,
Yang Yuwei
(Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, China)
,
Mou Yanhua
(Department of Pharmacology, Shenyang Pharmaceutical University, China)
,
Wang Shaojie
(Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, China)
資料名:
Journal of Medicinal Chemistry
(Journal of Medicinal Chemistry)
巻:
63
号:
24
ページ:
15752-15772
発行年:
2020年
JST資料番号:
D0102A
ISSN:
0022-2623
CODEN:
JMCMAR
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)